Open Innovation as the Catalyst in the Personalized Medicine to Personalized Digital Medicine Transition

Personalized medicine (PM) bridges several disciplines for understanding and addressing prevalent, complex, or rare situations in human health (e.g., complex phenotyping, risk stratification, etc.); therefore, digital and technological solutions have been integrated in the field to boost innovation and new knowledge generation. The open innovation (OI) paradigm proposes a method by which to respectfully manage disruptive change in biomedical organizations, as experienced by many organizations during digital transformation and the COVID-19 pandemic. In this article, we focus on how this paradigm has catalyzed the transition from PM to personalized digital medicine in a large-volume research hospital. Methods, challenges, and results are discussed. This case study is an endeavor to confirm that CH strategies could help manage urgent needs from the healthcare environment, while achieving sustainability-oriented, accountable innovation.

Automated summary

Personalized medicine utilizes digital and technological solutions to drive innovation and generate new knowledge, while the open innovation paradigm effectively manages transformation in healthcare organizations. This article examines the transition from personalized medicine to personalized digital medicine in a large research hospital, discussing methods, challenges, and results.